Observational studyScientific reports2022
Excess all-cause mortality in the USA and Europe during the COVID-19 pandemic, 2020 and 2021.
Observational study in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Change of antidepressant utilization in children, adolescents and young adults in Europe before and during the COVID-19 pandemic: a systematic review.European child & adolescent psychiatry · 2026Pooled it
- National trends and disparities in Alzheimer disease's mortality (1999-2023) with scenario projections and a data-driven LSTM sensitivity analysis to 2043.European archives of psychiatry and clinical neuroscience · 2026Article
- Excess Mortality During the COVID-19 Pandemic in Sonora, Mexico, 2015-2022: A Time-Series Analysis of Cause-Specific Mortality.Epidemiologia (Basel, Switzerland) · 2026Article
- Article
- Genetic polymorphisms and expression of SARS-CoV-2 host entry genes associate with COVID-19 severity in an unvaccinated Moroccan cohort.BMC medical genomics · 2026Article
- Excess mortality and underlying causes of death during the COVID-19 pandemic in rural Bangladesh: insights from the Matlab health and demographic surveillance system.Population health metrics · 2026Article
- Association of Shift, Day, Month and Year with Mortality: Observational Study of Spanish and USA Emergency Care Cohorts.Medical sciences (Basel, Switzerland) · 2026Observational
- Excess life-years and productive life-years lost in Poland through the COVID-19 pandemic and post-pandemic years.Archives of public health = Archives belges de sante publique · 2026Article
- Collaboration Networks, Trends, and Scientific Impact in Avoidable Mortality Research (2000-2024): A Bibliometric Study.BioMed research international · 2026Article
- Trends and demographic inequalities in mortality of the Lithuanian population during the COVID-19 pandemic: who suffered most?Population health metrics · 2025Article
- Excess respiratory, circulatory, neoplasm, and other mortality rates during the Covid-19 pandemic in the EU and their implications.Epidemiology and infection · 2025Article
- The impact of the pandemic on non-COVID-19 causes of death in the United States: a multiple cause of death analysis.European journal of epidemiology · 2025Article
- Combating the rising tide of kidney advocacy in Europe: the seminal role of the European Kidney Health Alliance (EKHA).Clinical kidney journal · 2025Review
- Beyond death counts: how COVID-19 affected excess mortality and productive life-years lost across 28 European states, 2020-2023.Frontiers in public health · 2025Article
- Financial impact of pandemics on pension sustainability: an application for Spain.Decisions in economics and finance · 2025Article
- Patterns and drivers of excess mortality during the COVID-19 pandemic in 13 Western European countries.BMC global and public health · 2024Article
- The faces of Long-COVID: interplay of symptom burden with socioeconomic, behavioral and healthcare factors.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024Article
- Excess Death Rates by State During the COVID-19 Pandemic: United States, 2020‒2023.American journal of public health · 2024Article
- Impact of the COVID-19 Pandemic on Conduct and Results of CLEAR Outcomes Trial.Clinical cardiology · 2024Article
- Month-to-month all-cause mortality forecasting: a method allowing for changes in seasonal patterns.American journal of epidemiology · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Both the USA and Europe experienced substantial excess mortality in 2020 and 2021 related to the COVID-19 pandemic. Methods used to estimate excess mortality vary, making comparisons difficult. This retrospective observational study included data on deaths from all causes occurring in the USA and 25 European countries or subnational areas participating in the network for European monitoring of excess mortality for public health action (EuroMOMO). We applied the EuroMOMO algorithm to estimate excess all-cause mortality in the USA and Europe during the first two years of the COVID-19 pandemic, 2020-2021, and compared excess mortality by age group and time periods reflecting three primary waves. During 2020-2021, the USA experienced 154.5 (95% Uncertainty Interval [UI]: 154.2-154.9) cumulative age-standardized excess all-cause deaths per 100,000 person years, compared with 110.4 (95% UI: 109.9-111.0) for the European countries. Excess all-cause mortality in the USA was higher than in Europe for nearly all age groups, with an additional 44.1 excess deaths per 100,000 person years overall from 2020-2021. If the USA had experienced an excess mortality rate similar to Europe, there would have been approximately 391 thousand (36%) fewer excess deaths in the USA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.